EFDA registers the medicine; a licensed Ethiopian importer clears every shipment.

EFDA controls the medicine. The Ethiopian importer holds the licence.

The Ethiopian Food and Drug Authority (EFDA) is the national regulator for medicines, medical devices and food. It runs two separate approval tracks that buyers often conflate. The first is product registration: market authorisation for a specific medicine, granted through EFDA's online i-Register system. The second is import authorisation: the licence and permit that let a specific Ethiopian entity bring registered stock into the country.

A foreign manufacturer or exporter, including M Care Exports, is not the entity that holds EFDA authorisation. That sits with the Ethiopian importer: a locally licensed pharmaceutical importer, a hospital, EPSS for public-sector supply, or an NGO procurement office. The Indian side supplies the product dossier and manufacturing evidence that the Ethiopian applicant submits to EFDA, and later the invoice and certificates each consignment needs to clear.

This split matters at the enquiry stage. Before quoting a landed price, a buyer needs to know whether the molecule is already registered in Ethiopia under a comparable brand, or whether registration has to be filed from scratch. See WHO prequalification vs national registration for how that choice affects timelines everywhere, not just Ethiopia.

Product registration: standard review, or the WHO-PQ collaborative route

Standard registration goes through i-Register with a full technical dossier: administrative documents, quality data (CMC), and non-clinical and clinical summaries in CTD format, plus site GMP evidence. EFDA reviews the dossier and may request additional data or a site inspection before granting market authorisation.

EFDA also operates a Collaborative Registration Procedure (CRP) for medicines that already hold WHO prequalification, and separately relies on approvals from Stringent Regulatory Authorities (SRAs) it has prelisted. For a WHO-prequalified product, EFDA can lean on WHO's own assessment rather than re-running a full review from zero, which is the closest thing to an accelerated pathway that EFDA operates. This only applies where the specific product and manufacturing site actually carry WHO-PQ status or SRA approval, not to WHO-GMP compliance alone.

EFDA publishes its current dossier requirements, application fees and review timelines through its own portal and guideline documents. Because these change and vary by product category, we work from what is published at the time of filing rather than quoting a fixed number here.

Preparing the CTD dossier, GMP and stability package correctly the first time is what keeps registration on track. Our dossier preparation (CTD) service builds this pack against EFDA's current checklist.

The import permit layer: a licence, then a permit per shipment

Registration alone does not let anyone bring stock across the border. The Ethiopian importer needs its own Certificate of Competence from EFDA, issued through the i-License system. To get and keep one, the importer must operate compliant storage (temperature and humidity controlled, with logged monitoring) and employ a full-time, licensed pharmacist as technical manager.

With a valid Certificate of Competence and a registered product, the importer applies for a pre-import permit for each consignment through i-Import. At the port, EFDA checks the shipment's documents, typically the import permit or approved purchase order, the proforma invoice, and the certificate of analysis, against the registration on file before releasing the goods.

EFDA also operates a separate special import permit route for specific, narrow circumstances: unregistered medicines needed for disaster or emergency response, diplomatic missions, or unmet medical need such as orphan drugs or treatments for seriously debilitating or life-threatening conditions. This is not a general-purpose shortcut around registration for ordinary commercial supply.

Public procurement runs through EPSS

Most public-sector medicine supply in Ethiopia is centralised through the Ethiopian Pharmaceuticals Supply Service (EPSS), which procures against its own national Pharmaceuticals Procurement List and floats competitive tenders through Ethiopia's e-Government Procurement (e-GP) system. Winning an EPSS tender is a separate exercise from EFDA registration: the product still has to be EFDA-registered (or covered by the tender's own regulatory terms) before it can be supplied against an award.

Bid documentation, pricing structure and delivery terms for a centralised tender look different from a private import deal, and the paperwork discipline is comparable to what we cover for Kenya's KEMSA process in Kenya: KEMSA tenders and PPB registration. For the wider approach to structuring a tender response, see tender response support.

What the documentation pack from India actually contains

For a registration filing or a tender submission, the Indian side typically needs to provide:

• A Certificate of Pharmaceutical Product (COPP) in WHO format, issued by the Indian licensing authority for the manufacturing site and product.
• The site's current GMP certificate from its state or central licensing authority, or WHO-GMP certification where the manufacturer holds it.
• A full CTD-format technical dossier: quality (CMC), and non-clinical/clinical summary data as applicable to the product category.
• Batch-specific Certificates of Analysis and stability data supporting the shelf life claimed on the label.
• Commercial documents for each shipment: proforma invoice, packing list and any transport documentation, drawn up to match the EFDA registration exactly.

Mismatches between what is filed at registration and what appears on the shipment's invoice are a common cause of hold-ups at port inspection, not a shortage of the medicine itself.

Where M Care Exports fits in this chain

M Care Exports is a Mumbai-headquartered merchant-exporter, not a manufacturer. We do not hold WHO-GMP certification ourselves and we do not hold EFDA registration or import authorisation; those sit with the Ethiopian importer of record. What we do is source the product, whether an originator brand through licensed Indian channels or a generic from a WHO-GMP certified manufacturer, and assemble the COPP, GMP evidence, dossier and batch documentation that the Ethiopian applicant needs to file with EFDA or submit against an EPSS tender.

For an Ethiopian importer, hospital or NGO procurement team evaluating an Indian supplier, that means one documentation pack that matches across the registration file, the pre-import permit application and the shipment invoice, rather than three separate sets of paperwork assembled under pressure. See our Ethiopia market page for the products we currently support there, or start a specific request through request a medicine. Registered importers working with us regularly can set up a trade account to streamline repeat orders.

Frequently asked

Do I need EFDA registration to import medicines into Ethiopia?

Yes, for ordinary commercial supply. A medicine must hold EFDA product registration before it can be imported and sold in Ethiopia, and the importing entity must separately hold an EFDA Certificate of Competence plus a pre-import permit for the shipment. EFDA does grant special import permits for unregistered products in narrow cases, such as disaster response or unmet medical need, but this is not a route around registration for standard commercial import.

How long does EFDA registration take?

It depends on the product category, the completeness of the dossier, and which route applies. A standard filing goes through full technical review. A product that already holds WHO prequalification can go through EFDA's Collaborative Registration Procedure, which relies on WHO's own assessment and is generally faster than a standard filing. EFDA publishes current review timelines and fees on its own portal; we work from those published figures at the time of filing rather than quoting a fixed number that may be out of date.

Can WHO prequalification shortcut EFDA registration?

For a product that is itself WHO-prequalified, yes: EFDA operates a Collaborative Registration Procedure for WHO-PQ medicines and separately recognises approvals from a prelisted set of Stringent Regulatory Authorities. This applies to the specific product and manufacturing site holding that status, not to WHO-GMP compliance in general. A WHO-GMP certified manufacturer without product-level WHO-PQ still goes through EFDA's standard registration review.

Who holds the import licence, the Indian supplier or the Ethiopian buyer?

The Ethiopian buyer. EFDA issues the Certificate of Competence and the pre-import permit to the Ethiopian entity bringing the product in, whether that is a licensed importer, a hospital, EPSS, or an NGO procurement office. An Indian exporter, including M Care Exports, does not hold EFDA authorisation; our role is sourcing the product and preparing the documentation the Ethiopian applicant submits.

What documents does an Indian supplier need to provide for EFDA registration?

Typically a Certificate of Pharmaceutical Product in WHO format, the manufacturing site's GMP certificate, a CTD-format technical dossier covering quality and, where applicable, clinical data, batch Certificates of Analysis, and stability data supporting the labelled shelf life. Commercial documents for each shipment, including the proforma invoice, need to match the registration file exactly to avoid delays at port inspection.

Can M Care Exports supply against an EPSS tender?

We can support the sourcing and documentation side: product selection, pricing, COPP and GMP evidence, dossier support and tender-ready paperwork. EPSS tenders run through Ethiopia's e-Government Procurement system and require the product to be EFDA-registered (or covered under the tender's own terms), and a locally licensed entity to act as the importer of record. Get in touch through request a medicine to work through what a specific tender needs.